From post-operative dressings to skin graft fixation, Mölnlycke Health Care provides a range of Wound Care products that offer superior protection and performance for both patient and clinician. Biogel, Hibiclens, Barrier, and Mölnlycke Wound Care products set a new standard in infection control, surgical care and patient comfort.
In 2007, the CDC projected that 1.7 million patients would contract an infection in a hospital in the U.S., and 22% of these account for surgical site infections (SSIs). Click here to read more.
New restrictions on CMS reimbursements effective October 1, 2008, are forcing hospitals to become more accountable for SSI-related costs. In light of the new payment guidelines for HAIs and preventable conditions, Mölnlycke Wound Care offers a range of products to assist clinicians in preventing, protecting and/or treating wounds while at the same time providing less trauma and pain for patients.
The Mölnlycke Health Care, Barrier, Biogel, Hibiclens, Safetac, Mepitel, Mepilex, and Mepore names and respective logos are registered trademarks Mölnlycke Health Care AB. Distributed by Mölnlycke Health Care US, LLC, Norcross, Georgia 30092. © 2008. Mölnlycke Health Care AB. 1.800.882.4582.
